Literature DB >> 17668171

[Prediction of tumor recurrence and progression of superficial bladder carcinoma using an artificial neural network].

B Planz1, T Deix, H P Caspers.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17668171     DOI： 10.1007/s00120-007-1465-8

Source DB:  PubMed          Journal:  Urologe A        ISSN： 0340-2592            Impact factor:   0.639


× No keyword cloud information.
  10 in total

1.  Survivin nuclear labeling index: a superior biomarker in superficial urothelial carcinoma of human urinary bladder.

Authors:  Wu Yin; Ni Chen; Yutao Zhang; Hao Zeng; Xueqin Chen; Yongtao He; Xiaojie Wang; Qiao Zhou
Journal:  Mod Pathol       Date:  2006-08-04       Impact factor: 7.842

2.  An artificial neural network for prostate cancer staging when serum prostate specific antigen is 10 ng./ml. or less.

Authors:  Alexandre R Zlotta; Mesut Remzi; Peter B Snow; Claude C Schulman; Michael Marberger; Bob Djavan
Journal:  J Urol       Date:  2003-05       Impact factor: 7.450

3.  The epidermal growth factor receptor and the prognosis of bladder cancer.

Authors:  D E Neal; L Sharples; K Smith; J Fennelly; R R Hall; A L Harris
Journal:  Cancer       Date:  1990-04-01       Impact factor: 6.860

4.  Promoter hypermethylation identifies progression risk in bladder cancer.

Authors:  David R Yates; Ishtiaq Rehman; Maysam F Abbod; Mark Meuth; Simon S Cross; Derek A Linkens; Freddie C Hamdy; James W F Catto
Journal:  Clin Cancer Res       Date:  2007-04-01       Impact factor: 12.531

5.  Primary superficial bladder cancer risk groups according to progression, mortality and recurrence.

Authors:  F Millán-Rodríguez; G Chéchile-Toniolo; J Salvador-Bayarri; J Palou; F Algaba; J Vicente-Rodríguez
Journal:  J Urol       Date:  2000-09       Impact factor: 7.450

6.  Artificial neural networks improve the accuracy of cancer survival prediction.

Authors:  H B Burke; P H Goodman; D B Rosen; D E Henson; J N Weinstein; F E Harrell; J R Marks; D P Winchester; D G Bostwick
Journal:  Cancer       Date:  1997-02-15       Impact factor: 6.860

7.  An immunohistologic evaluation of C-erbB-2 gene product in patients with urinary bladder carcinoma.

Authors:  K Sato; M Moriyama; S Mori; M Saito; T Watanuki; K Terada; E Okuhara; T Akiyama; K Toyoshima; T Yamamoto
Journal:  Cancer       Date:  1992-11-15       Impact factor: 6.860

8.  Factors affecting recurrence and progression in superficial bladder tumours.

Authors:  K H Kurth; L Denis; C Bouffioux; R Sylvester; F M Debruyne; M Pavone-Macaluso; W Oosterlinck
Journal:  Eur J Cancer       Date:  1995-10       Impact factor: 9.162

9.  Nuclear overexpression of p53 protein in transitional cell bladder carcinoma: a marker for disease progression.

Authors:  A S Sarkis; G Dalbagni; C Cordon-Cardo; Z F Zhang; J Sheinfeld; W R Fair; H W Herr; V E Reuter
Journal:  J Natl Cancer Inst       Date:  1993-01-06       Impact factor: 13.506

10.  p53 nuclear protein accumulation correlates with mutations in the p53 gene, tumor grade, and stage in bladder cancer.

Authors:  D Esrig; C H Spruck; P W Nichols; B Chaiwun; K Steven; S Groshen; S C Chen; D G Skinner; P A Jones; R J Cote
Journal:  Am J Pathol       Date:  1993-11       Impact factor: 4.307
  10 in total
  1 in total

1.  Prediction of vestibular schwannoma recurrence using artificial neural network.

Authors:  Mehdi Abouzari; Khodayar Goshtasbi; Brooke Sarna; Pooya Khosravi; Trevor Reutershan; Navid Mostaghni; Harrison W Lin; Hamid R Djalilian
Journal:  Laryngoscope Investig Otolaryngol       Date:  2020-02-17
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.